The objective of this interdisciplinary study is to elucidate the specific role of the ascending serotonergic (5-HT) and noradrenergic (NE) projections upon the functional properties of neurons in primate neocortex and to test the hypothesis that these neurotransmitters regulate the discharge patterns of cortical neurons that are active in specific behavioral and cognitive tasks. Extracellular recording techniques will be employed to monitor patterns of neuronal discharge and of directionality of single neurons in motor, premotor and pariental cortex in awake, behaving monkeys. Patterns of neuronal activity will be compared in normal cortex, in zones locally depleted of 5-HT or NE and after iontophoretic replacement of these neurotransmitters. For these studies, localized zones of cortex will be selectively ablated of 5-HT or NE axons by micro-injections of specific neurotoxins. These denervated zones will be extensively characterized for selective depletion and non-specific damage by a battery of histologic, immunohistochemical, and biochemical measures. To determine whether monoaminergic neurons have localized or widespread effects upon neocortex, the topographic pattern of raphe-cortical projections will be analyzed by retrograde transport of fluorescent dyes, and the intracortical trajectory of monoamine axons will be determined by analysis of sections through the denervated cortical zones. This study should contribute new information, particularly relevant for man, concerning the functional organization of the monoamine neurons and should lead us to identify those parameters of cortical neuronal discharge that are influenced by these brainstem projections. These neurons, which are affected by widely used psychotropic drugs, are involved in cognitive functions and may regulate vigilance, mood, sleep, and attention; abnormalities of these neuron systems have been implicated in neurologic and pshychiatric disorders, especially in manic-depressive psychoses and in the dementias.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS021011-02
Application #
3401717
Study Section
Neurology B Subcommittee 1 (NEUB)
Project Start
1984-07-01
Project End
1987-06-30
Budget Start
1985-07-01
Budget End
1986-06-30
Support Year
2
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Wilson, M A; Molliver, M E (1991) The organization of serotonergic projections to cerebral cortex in primates: retrograde transport studies. Neuroscience 44:555-70
Wilson, M A; Molliver, M E (1991) The organization of serotonergic projections to cerebral cortex in primates: regional distribution of axon terminals. Neuroscience 44:537-53
Molliver, M E; Berger, U V; Mamounas, L A et al. (1990) Neurotoxicity of MDMA and related compounds: anatomic studies. Ann N Y Acad Sci 600:649-61;discussion 661-4
Ricaurte, G A; Finnegan, K T; Irwin, I et al. (1990) Aminergic metabolites in cerebrospinal fluid of humans previously exposed to MDMA: preliminary observations. Ann N Y Acad Sci 600:699-708;discussion 708-10
Wilson, M A; Ricaurte, G A; Molliver, M E (1989) Distinct morphologic classes of serotonergic axons in primates exhibit differential vulnerability to the psychotropic drug 3,4-methylenedioxymethamphetamine. Neuroscience 28:121-37
Kitt, C A; Walker, L C; Molliver, M E et al. (1989) Serotoninergic neurites in senile plaques in cingulate cortex of aged nonhuman primate. Synapse 3:12-8
Molliver, M E; Mamounas, L A; Wilson, M A (1989) Effects of neurotoxic amphetamines on serotonergic neurons: immunocytochemical studies. NIDA Res Monogr 94:270-305
Georgopoulos, A P; Crutcher, M D; Schwartz, A B (1989) Cognitive spatial-motor processes. 3. Motor cortical prediction of movement direction during an instructed delay period. Exp Brain Res 75:183-94
O'Hearn, E; Battaglia, G; De Souza, E B et al. (1988) Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity. J Neurosci 8:2788-803
Ricaurte, G A; Forno, L S; Wilson, M A et al. (1988) (+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates. JAMA 260:51-5

Showing the most recent 10 out of 13 publications